Date: 2025-06-14 16:23:37 Source: Author: Research Views: 121
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor
